Centessa Pharmaceuticals plc

We are leaders, innovators, and scientists aiming to pursue medicines that are transformational for patients.

CNTA Centessa Pharmaceuticals plc - Yahoo Finance

Centessa Pharmaceuticals plc (CNTA) · -4.36% · -0.56% · 82.03% · 101.01% · 121.91% · -20.99% · -20.99%.

Centessa Pharmaceuticals plc is a clinical-stage pharmaceutical company with a Research & Development innovation engine that aims to ...

Centessa Pharmaceuticals PLC - Company Profile and News

Company profile page for Centessa Pharmaceuticals PLC including stock price, company news, executives, board members, and contact information.

CENTESSA PHARMACEUTICALS PLC overview - Companies House

CENTESSA PHARMACEUTICALS PLC - Free company information from Companies House including registered office address, filing history, accounts, annual return, ...

Centessa Pharmaceuticals plc - AnnualReports.co.uk

Centessa Pharmaceuticals plc ... Centessa Pharmaceuticals plc is a clinical-stage pharmaceutical company with a Research & Development innovation engine that aims ...

Centessa Pharmaceuticals plc - AnnualReports.com

Centessa Pharmaceuticals plc ... Centessa Pharmaceuticals plc is a clinical-stage pharmaceutical company with a Research & Development innovation engine that aims ...

Centessa Pharmaceuticals PLC 260-FF:Frankfurt Stock Exchange

Get Centessa Pharmaceuticals PLC (260-FF:Frankfurt Stock Exchange) real-time stock quotes, news, price and financial information from CNBC.

ADR (CNTA) Price & News - Centessa Pharmaceuticals PLC - Google

Get the latest Centessa Pharmaceuticals PLC - ADR (CNTA) real-time quote, historical performance, charts, and other financial information to help you make ...

Centessa Pharmaceuticals - X.com

12, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines ...

Centessa Pharmaceuticals Reports Financial Results for the

Centessa Pharmaceuticals plc is a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational ...

Centessa Pharmaceuticals plc American Depositary Shares (CNTA)

Discover real-time Centessa Pharmaceuticals plc American Depositary Shares (CNTA) stock prices, quotes, historical data, news, and Insights for informed ...

Centessa Pharmaceuticals - Crunchbase Company Profile & Funding

Centessa Pharmaceuticals is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process.

Centessa Pharmaceuticals Company Profile 2024 - PitchBook

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for ...

Centessa Pharmaceuticals Announces $150,000,000 Proposed ...

Centessa Pharmaceuticals plc is a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational ...

Centessa Pharmaceuticals Plc (CNTA): A Small-Cap Leader in ...

We recently published a list of 10 Small Cap Stocks with High Potential. In this article, we are going to take a look at where Centessa ...

CENTESSA PHARMACEUTICALS PLC people - Companies House

CENTESSA PHARMACEUTICALS PLC - Free company information from Companies House including registered office address, filing history, accounts, annual return, ...

Centessa Pharmaceuticals plc - The Rosen Law Firm

Centessa Pharmaceuticals plc (NASDAQ: CNTA) resulting from allegations that Centessa Pharmaceuticals may have issued materially misleading business information.

Centessa Pharmaceuticals plc (CNTA) Company Profile & Overview

Company Description. Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines for patients. Its ...

Centessa Pharmaceuticals PLC, CNTA:NSQ summary - FT.com

As of last trade Centessa Pharmaceuticals PLC (CNTA:NSQ) traded at 16.80, -10.35% below its 52-week high of 18.74, set on Nov 13, 2024.